Literature DB >> 16943577

Plasma adiponectin and insulin resistance in new onset hypertension.

Teoman Dogru1, Alper Sonmez, Ilker Tasci, M Ilker Yilmaz, Selim Kilic, Taner Ozgurtas, Tayfun Eyileten, M Kemal Erbil, I Hakki Kocar.   

Abstract

OBJECTIVE: The data related to association among hypertension, insulin resistance, and plasma adiponectin concentration is controversial. We aimed to evaluate the relationships among these factors in a young hypertensive group who had no confounding factors. DESIGN AND METHODS: Thirty newly diagnosed and formerly untreated hypertensive males (mean age 23.4 +/- 4.0 yr; body mass index: 24.9 +/- 2.2 kg/m2), and 60 healthy control subjects (mean age 22.5 +/- 3.2 yr; body mass index: 24.6 +/- 1.6 kg/m2) were enrolled. Insulin resistance was calculated by homeostasis model assessment (HOMA).
RESULTS: The two groups were similar in terms of age, body mass index, fasting glucose, total cholesterol, HDL and LDL cholesterol, adiponectin, insulin, HOMA, and hsCRP levels. Mean triglyceride levels in hypertensive patients were significantly higher than the controls (p = 0.02).
CONCLUSIONS: These results indicate that young, newly diagnosed, uncomplicated patients with hypertension have similar plasma adiponectin levels and insulin sensitivities when compared to healthy controls. We suggest that high blood pressure itself may not be associated with insulin resistance or low adiponectin levels in patients with new onset, uncomplicated hypertension.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16943577     DOI: 10.1385/ENDO:29:3:405

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  40 in total

1.  Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate.

Authors:  F S Facchini; R A Stoohs; G M Reaven
Journal:  Am J Hypertens       Date:  1996-10       Impact factor: 2.689

2.  Serum-insulin in essential hypertension and in peripheral vascular disease.

Authors:  T A Welborn; A Breckenridge; A H Rubinstein; C T Dollery; T R Fraser
Journal:  Lancet       Date:  1966-06-18       Impact factor: 79.321

3.  Insulin resistance is a characteristic feature of primary hypertension independent of obesity.

Authors:  T Pollare; H Lithell; C Berne
Journal:  Metabolism       Date:  1990-02       Impact factor: 8.694

4.  Is C-reactive protein an independent risk factor for essential hypertension?

Authors:  L E Bautista; P López-Jaramillo; L M Vera; J P Casas; A P Otero; A I Guaracao
Journal:  J Hypertens       Date:  2001-05       Impact factor: 4.844

5.  Adiponectin in essential hypertension.

Authors:  Francesca Mallamaci; Carmine Zoccali; Fortunata Cuzzola; Giovanni Tripepi; Sebastiano Cutrupi; Saverio Parlongo; Sachiyo Tanaka; Noriyuki Ouchi; Shinji Kihara; Tohru Funahashi; Yuji Matsuzawa
Journal:  J Nephrol       Date:  2002 Sep-Oct       Impact factor: 3.902

6.  Peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist increases plasma adiponectin levels in type 2 diabetic patients with proteinuria.

Authors:  Mahmut Ilker Yilmaz; Alper Sonmez; Kayser Caglar; Deniz Engin Gok; Tayfun Eyileten; Müjdat Yenicesu; Cengizhan Acikel; Necati Bingol; Selim Kilic; Yusuf Oguz; Abdulgaffar Vural
Journal:  Endocrine       Date:  2004-12       Impact factor: 3.633

7.  Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population.

Authors:  Yukihiro Yamamoto; Hiroshi Hirose; Ikuo Saito; Motowo Tomita; Matsuo Taniyama; Koichi Matsubara; Yasunori Okazaki; Tatsuya Ishii; Kanako Nishikai; Takao Saruta
Journal:  Clin Sci (Lond)       Date:  2002-08       Impact factor: 6.124

8.  Insulin sensitivity and body fat distribution in normotensive offspring of hypertensive parents.

Authors:  Y Allemann; F F Horber; M Colombo; P Ferrari; S Shaw; P Jaeger; P Weidmann
Journal:  Lancet       Date:  1993-02-06       Impact factor: 79.321

9.  Decreased plasma adiponectin concentrations in women with dyslipidemia.

Authors:  Miyao Matsubara; Shoji Maruoka; Shinji Katayose
Journal:  J Clin Endocrinol Metab       Date:  2002-06       Impact factor: 5.958

10.  Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression.

Authors:  Philip A Kern; Gina B Di Gregorio; Tong Lu; Negah Rassouli; Gouri Ranganathan
Journal:  Diabetes       Date:  2003-07       Impact factor: 9.461

View more
  2 in total

1.  Regulation of adiponectin gene expression in adipose tissue by thyroid hormones.

Authors:  Samira Seifi; Mohammad Reza Tabandeh; Saed Nazifi; Mehdi Saeb; Sadegh Shirian; Parisa Sarkoohi
Journal:  J Physiol Biochem       Date:  2011-11-30       Impact factor: 4.158

2.  Adiponectin is not associated with blood pressure in normotensives and untreated hypertensives with normal kidney function.

Authors:  Vanja Ivković; Mislav Jelaković; Mario Laganović; Ivan Pećin; Ana Vrdoljak; Sandra Karanović; Mirjana Fuček; Tamara Božina; Jelena Kos; Tajana Željković Vrkić; Vedran Premužić; Marijana Živko; Bojan Jelaković
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.